SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021345
Filing Date
2018-08-13
Accepted
2018-08-10 20:08:52
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20180630.htm 10-Q 2119019
2 EX-31.1 flgt-ex311_8.htm EX-31.1 19174
3 EX-31.2 flgt-ex312_6.htm EX-31.2 18841
4 EX-32.1 flgt-ex321_7.htm EX-32.1 18021
  Complete submission text file 0001564590-18-021345.txt   7677907

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flgt-20180630.xml EX-101.INS 1953643
6 XBRL TAXONOMY EXTENSION SCHEMA flgt-20180630.xsd EX-101.SCH 44613
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20180630_cal.xml EX-101.CAL 39863
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20180630_def.xml EX-101.DEF 137695
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20180630_lab.xml EX-101.LAB 318232
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20180630_pre.xml EX-101.PRE 258269
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 181010075
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences